This inventor holds 2 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, Institut Curie. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 8,819 
2 out of 162 
Years Active: 2013-2015
Title: Siau-Kun Bai: Innovator in Shiga Toxin Research
Introduction
Siau-Kun Bai is a notable inventor based in Villeneuve Saint-Georges, France. He has made significant contributions to the field of medical research, particularly in the development of treatments related to Shiga toxins. With a total of 2 patents to his name, Bai's work is recognized for its potential impact on public health.
Latest Patents
Siau-Kun Bai's latest patents focus on inhibitors of Shiga toxins trafficking through the retrograde pathway. The inventions relate to the use of compounds of general formula (I) and (II) for the preparation of drugs aimed at preventing and/or treating disorders caused by Shiga toxins and related toxins. These innovations highlight his commitment to addressing critical health issues.
Career Highlights
Throughout his career, Siau-Kun Bai has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Institut Curie. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Siau-Kun Bai has collaborated with notable colleagues, including Daniel Gillet and Julien Barbier. These partnerships have further enriched his research and development efforts.
Conclusion
Siau-Kun Bai's contributions to the field of medical research, particularly in the area of Shiga toxins, demonstrate his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing scientific knowledge and developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile